179 related articles for article (PubMed ID: 15654351)
21. Natural killer cells: biology and clinical use in cancer therapy.
Hallett WH; Murphy WJ
Cell Mol Immunol; 2004 Feb; 1(1):12-21. PubMed ID: 16212916
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cells in the treatment of high-risk acute leukaemia.
Locatelli F; Moretta F; Brescia L; Merli P
Semin Immunol; 2014 Apr; 26(2):173-9. PubMed ID: 24613727
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D
Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421
[TBL] [Abstract][Full Text] [Related]
24. Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors.
Kim DH; Sohn SK; Lee NY; Baek JH; Kim JG; Won DI; Suh JS; Lee KB; Shin IH
Eur J Haematol; 2005 Oct; 75(4):299-308. PubMed ID: 16146536
[TBL] [Abstract][Full Text] [Related]
25. [Influence factors of reconstitution of killer cell immunoglobulin-like receptor on NK cells following non-T-cell-depleted haploidentical hematopoietic stem cell transplantation].
Zhao XY; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):103-6. PubMed ID: 17650670
[TBL] [Abstract][Full Text] [Related]
26. The role of natural killer cells in hematopoietic stem cell transplantation.
Tsirigotis PD; Resnick IB; Shapira MY
Ann Med; 2012 Mar; 44(2):130-45. PubMed ID: 21410396
[TBL] [Abstract][Full Text] [Related]
27. Role of KIRs and KIR ligands in hematopoietic transplantation.
Velardi A
Curr Opin Immunol; 2008 Oct; 20(5):581-7. PubMed ID: 18675345
[TBL] [Abstract][Full Text] [Related]
28. Natural killer cells--new understanding of basic biology may lead to more effective allogeneic haematopoietic stem cell transplantation.
Patil S; Schwarer T
Intern Med J; 2009 Oct; 39(10):639-47. PubMed ID: 19686544
[TBL] [Abstract][Full Text] [Related]
29. Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation.
Ruggeri L; Mancusi A; Burchielli E; Aversa F; Martelli MF; Velardi A
Cytotherapy; 2006; 8(6):554-8. PubMed ID: 17148031
[TBL] [Abstract][Full Text] [Related]
30. On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies.
Dellabona P; Casorati G; de Lalla C; Montagna D; Locatelli F
Clin Immunol; 2011 Aug; 140(2):152-9. PubMed ID: 21185785
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy by allogeneic stem cell transplantation.
Ringdén O
Adv Cancer Res; 2007; 97():25-60. PubMed ID: 17419940
[TBL] [Abstract][Full Text] [Related]
32. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
[TBL] [Abstract][Full Text] [Related]
33. Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation.
Sangiolo D; Mesiano G; Carnevale-Schianca F; Piacibello W; Aglietta M; Cignetti A
Expert Opin Biol Ther; 2009 Jul; 9(7):831-40. PubMed ID: 19463075
[TBL] [Abstract][Full Text] [Related]
34. Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.
Kim SY; Choi HB; Yoon HY; Choi EJ; Cho B; Kim HK; Kim YJ; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Kim CC; Kim TG
Tissue Antigens; 2007 Apr; 69 Suppl 1():114-7. PubMed ID: 17445182
[TBL] [Abstract][Full Text] [Related]
35. Killer cell Ig-like receptors ligand-mismatched, alloreactive natural killer cells lyse primary solid tumors.
Re F; Staudacher C; Zamai L; Vecchio V; Bregni M
Cancer; 2006 Aug; 107(3):640-8. PubMed ID: 16804934
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cell alloreactivity 10 years later.
Velardi A
Curr Opin Hematol; 2012 Nov; 19(6):421-6. PubMed ID: 22954728
[TBL] [Abstract][Full Text] [Related]
37. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
Chang YJ; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
[TBL] [Abstract][Full Text] [Related]
38. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
Eur J Haematol; 2007 Apr; 78(4):338-46. PubMed ID: 17378893
[TBL] [Abstract][Full Text] [Related]
39. Shared biology of GVHD and GVT effects: potential methods of separation.
Fowler DH
Crit Rev Oncol Hematol; 2006 Mar; 57(3):225-44. PubMed ID: 16207532
[TBL] [Abstract][Full Text] [Related]
40. NK cell-mediated immune response against cancer.
Moretta L
Surg Oncol; 2007 Dec; 16 Suppl 1():S3-5. PubMed ID: 18032029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
